1. Home
  2. MDBH vs HBIO Comparison

MDBH vs HBIO Comparison

Compare MDBH & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

N/A

Current Price

$3.27

Market Cap

36.7M

Sector

N/A

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.58

Market Cap

33.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
HBIO
Founded
1997
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
36.7M
33.8M
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
MDBH
HBIO
Price
$3.27
$0.58
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$2.50
AVG Volume (30 Days)
12.2K
326.3K
Earning Date
11-13-2025
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.76
N/A
Revenue
$1,250,398.00
$87,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.80
P/E Ratio
$4.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.11
$0.28
52 Week High
$7.98
$1.84

Technical Indicators

Market Signals
Indicator
MDBH
HBIO
Relative Strength Index (RSI) 42.26 39.78
Support Level $3.21 $0.57
Resistance Level $3.48 $0.63
Average True Range (ATR) 0.16 0.04
MACD -0.03 -0.00
Stochastic Oscillator 9.93 20.71

Price Performance

Historical Comparison
MDBH
HBIO

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: